J Korean Soc Plast Reconstr Surg.  2006 Sep;33(5):627-631.

Treatment of Recurrent Ischial Pressure Sore Using Sclerotherapy with Absolute Ethanol

Affiliations
  • 1Department of Plastic and Reconstructive Surgery, National Medical Center, Seoul, Korea. hsong24@nate.com

Abstract

PURPOSE
Ischial region is common site of pressure sore as well as greater trochanteric area. In general, ischial pressure sore associated with a large subcutaneous bursa often requires radical surgical treatment. The authors performed sclerotherapy using absolute ethanol which was considered as an alternative in treating recurrent ischial pressure sore.
METHODS
From may 2005 to February 2006, 11 ischial pressure sore patients were treated sclerotherapy using absolute ethanol. The authors performed sclerotherapy using absolute ethanol in 11 patients in whom the ischial sore has recurred despite of multiple radical surgical treatment. The patients' original disorders were spinal cord injury in 9 patients, cerebral palsy in 1 patient and giant cell tumor in thoracic vertebrae 1 patient.
RESULTS
Recurrence of pressure sore was not found in any patient during the follow-up period. The swap of the bursa taken before the surgery was germ cultured and compared with the discharge from an end of the inserted drain tube. The germ cultured results after the surgery were tested negative in all patients.
CONCLUSION
This method involves causing the bursa to become scarred and closing it up by sterilizing, fixing, and denaturing by the pharmacologic effect of absolute ethanol instead of surgical excision of the bursa. We felt that aforementioned treatment modality may be considered as an alternative in treating recurrentischial pressure sore.

Keyword

Absolute ethanol; Sclerotherapy; Pressure sore

MeSH Terms

Cerebral Palsy
Cicatrix
Ethanol*
Femur
Follow-Up Studies
Giant Cell Tumors
Humans
Pressure Ulcer*
Recurrence
Sclerotherapy*
Spinal Cord Injuries
Thoracic Vertebrae
Ethanol
Full Text Links
  • JKSPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr